Stock Events

Stock Events

Voyageur Pharmaceuticals 

$0.08
4
-$0-0% Thursday 13:30

Statistics

Day High
0.08
Day Low
0.08
52W High
0.25
52W Low
0
Volume
10,000
Avg. Volume
-
Mkt Cap
14.27M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3AugExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-2.5MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VYYRF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its pharmaceutical segment, competes in developing medical products including those in the mineral and healthcare sectors similar to Voyageur Pharmaceuticals.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a major player in the pharmaceutical industry, developing drugs and treatments that may overlap with the mineral-based products offered by Voyageur Pharmaceuticals.
Merck
MRK
Mkt Cap277.02B
Merck & Co., Inc. operates in the pharmaceutical sector, producing health solutions that can compete with the mineral-based pharmaceuticals developed by Voyageur.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline focuses on a broad range of pharmaceutical products, potentially competing in the same healthcare segments as Voyageur Pharmaceuticals.
Novartis
NVS
Mkt Cap279.67B
Novartis AG, with its extensive range of pharmaceutical products, competes in various therapeutic areas that might intersect with Voyageur’s offerings.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie Inc. competes in the global pharmaceutical market, potentially overlapping with Voyageur’s niche in mineral-based pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol-Myers Squibb operates in multiple pharmaceutical areas, which could include competition in sectors targeted by Voyageur Pharmaceuticals.
Lilly(Eli) &
LLY
Mkt Cap862.01B
Eli Lilly and Company develops a wide array of pharmaceutical products that could compete with Voyageur’s specialized mineral-based treatments.
Sanofi
SNY
Mkt Cap110.4B
Sanofi engages in the development and marketing of pharmaceutical products that may compete with the offerings from Voyageur Pharmaceuticals.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca operates globally in various pharmaceutical sectors, potentially competing with Voyageur Pharmaceuticals in certain healthcare markets.

About

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The company has a collaboration with Bayer for the research and development of evaluating potential future production of iodine to be used in contrast media drugs. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The company is headquartered in Calgary, Canada.
Show more...
CEO
Mr. Brent Willis Bsc.Eng
Employees
6
Country
Canada
ISIN
CA92918C1014

Listings

OTC Link
US
VYYRF
V
CA
VM.V

0 Comments

Share your thoughts

FAQ

What is Voyageur Pharmaceuticals stock price today?▼
The current price of VYYRF is $0.08 USD — it has decreased by -0% in the past 24 hours. Watch Voyageur Pharmaceuticals stock price performance more closely on the chart.
What is Voyageur Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Voyageur Pharmaceuticals stocks are traded under the ticker VYYRF.
What is Voyageur Pharmaceuticals market cap?▼
Today Voyageur Pharmaceuticals has the market capitalization of 14.27M
When is the next Voyageur Pharmaceuticals earnings date?▼
Voyageur Pharmaceuticals is going to release the next earnings report on August 03, 2026.
What is Voyageur Pharmaceuticals revenue for the last year?▼
Voyageur Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Voyageur Pharmaceuticals net income for the last year?▼
VYYRF net income for the last year is -2.5M USD.
How many employees does Voyageur Pharmaceuticals have?▼
As of May 06, 2026, the company has 6 employees.
In which sector is Voyageur Pharmaceuticals located?▼
Voyageur Pharmaceuticals operates in the Health & Wellness sector.
When did Voyageur Pharmaceuticals complete a stock split?▼
Voyageur Pharmaceuticals has not had any recent stock splits.
Where is Voyageur Pharmaceuticals headquartered?▼
Voyageur Pharmaceuticals is headquartered in Calgary, Canada.